Nicotinic Receptors and Schizophrenia

Completed · Phase 1

Conditions studied: Schizophrenia

In brief

The study determines if a new preparation of a drug designed to treat schizophrenia is more slowly released into the body.

Key facts

Study ID

NCT00952393

Run by

VA Office of Research and Development

People needed

10

Starts

2010-01-01

Expected to finish

2014-10-01

Last updated by the study team

2016-02-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers: males and females who are incapable of pregnancy

You may not qualify if…

• Medical illnesses requiring acute treatment
• History of seizures
• Substance abuse including nicotine

Where it is running

• VA Eastern Colorado Health Care System, Denver — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.